You are here: Home » News-CM » Companies » News
Business Standard

Lupin and Eli Lilly expand partnership in India

Capital Market 

to market and sell Lilly's rapid action insulin analog Lispro Eglucent

and Eli Lilly and Company (India) announced an expansion of their partnership in with the launch of Eglucent, a new brand of Lilly's rapid action insulin analog Lispro.

According to the agreement, will market and sell Eglucent through its own specialty field force while Lilly will be responsible for manufacturing and import.

Powered by Capital Market - Live News

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Lupin and Eli Lilly expand partnership in India

Lupin to market and sell Lilly's rapid action insulin analog Lispro Eglucent

to market and sell Lilly's rapid action insulin analog Lispro Eglucent

and Eli Lilly and Company (India) announced an expansion of their partnership in with the launch of Eglucent, a new brand of Lilly's rapid action insulin analog Lispro.

According to the agreement, will market and sell Eglucent through its own specialty field force while Lilly will be responsible for manufacturing and import.

Powered by Capital Market - Live News

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Lupin and Eli Lilly expand partnership in India

to market and sell Lilly's rapid action insulin analog Lispro Eglucent

and Eli Lilly and Company (India) announced an expansion of their partnership in with the launch of Eglucent, a new brand of Lilly's rapid action insulin analog Lispro.

According to the agreement, will market and sell Eglucent through its own specialty field force while Lilly will be responsible for manufacturing and import.

Powered by Capital Market - Live News

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

image
Business Standard
177 22